Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PLSE
#1951
Pulse Biosciences, Inc Common Stock (DE)
18.730
0
-0.58%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.58%
Monatliche Änderung
+30.89%
6 month change
+3.20%
Jahresänderung
+3.20%
Vorheriger Schlusskurs
18.840
0
Open
18.730
0
Bid
Ask
Low
18.730
0
High
18.730
0
Volumen
54
Märkte
Aktien
Gesundheitswesen
PLSE
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
61.52 M
67.27 M
67.27 M
67.28 M
67.77 M
67.99 M
—
Valuation ratios
Enterprise value
999.97 M
1.05 B
963.16 M
908.88 M
1.1 B
852.76 M
3.83 B
Price to earnings ratio
-20.91
-18.97
-16.27
-14.04
-15.33
12.71
-32.93
Price to sales ratio
—
—
—
—
13.87 K
2 643.82
—
Price to cash flow ratio
-28.61
-27.98
-24.66
-21.68
-23.86
17.1
-53.09
Price to book ratio
5.24
8.85
2.93
2.29
2.66
11.47
19.35
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.14
0.15
0.13
0.16
0.18
-0.18
0.28
Return on equity %
0.16
0.17
0.14
0.18
0.21
-0.22
0.32
Return on invested capital %
387.93
574.96
511.05
591.32
—
356.75
—
Gross margin %
—
—
—
—
-224.42
100
—
Operating margin %
—
—
—
—
23.68 K
-6 914.02
—
EBITDA margin %
—
—
—
—
-23.57 K
—
—
Net margin %
—
—
—
—
22.54 K
-6 603.41
—
Liquidity ratios
Quick ratio
—
—
15.58
12.04
10.01
10.51
48.14
Current ratio
11.93
11.88
15.58
12.05
10.02
10.53
48.17
Inventory turnover
—
—
0
0
0
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.15
0.16
0.2
0.19
0.19
-0.22
0.37
EBIT per share
—
—
-0.12
-0.13
-0.31
—
—
EBITDA per share
—
—
-0.11
-0.12
-0.3
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.29
2.02
1.78
1.58
1.41
1.2
5.97
Net current asset value per share
1.32
2.05
1.8
1.61
1.44
1.24
6.09
Tangible book value per share
1.36
2.03
1.83
1.62
1.44
1.27
6.15
Working capital per share
1.21
1.87
1.69
1.47
1.3
1.12
5.58
Book value per share
1.3
1.97
1.76
1.55
1.38
1.2
5.89
Nachrichten
Pulse Biosciences chief commercial officer resigns effective immediately
Pulse Biosciences: CCO Danahy verkauft Aktien im Wert von 118.000 US-Dollar
Pulse Biosciences CCO Danahy sells $118k in PLSE stock
Pulse Biosciences: Oppenheimer erhöht Kursziel deutlich auf 30 $
Oppenheimer raises Pulse Biosciences stock price target to $30
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
Pulse Biosciences: EPS übertrifft Schätzungen um 0,07 $ - Umsatz schlechter als erwartet
Pulse Biosciences: Quartalszahlen nach Kurssprung durch Studiendaten im Fokus
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Pulse Biosciences: CCO Danahy verkauft Aktien im Wert von 1,41 Millionen US-Dollar
Pulse Biosciences CCO Danahy sells $1.41 million in stock